{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-009903","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.947030+00:00","generated_at":"2026-05-31T13:30:25.836485+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Dermata Therapeutics ups ATM offering by $505K to $1.66M total","bullets":["Increased maximum aggregate offering price under ATM agreement with H.C. Wainwright by $505,000 to $1,662,761.","Previously sold $1,157,247.99 of common stock under the June 7, 2024 Sales Agreement.","Additional $505,000 of shares authorized under the current prospectus supplement.","Legal opinion on share legality filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-009903","json":"https://secwatch.observer/filing/0001654954-24-009903.json","markdown":"https://secwatch.observer/filing/0001654954-24-009903.md","text":"https://secwatch.observer/filing/0001654954-24-009903.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000165495424009903/0001654954-24-009903-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000165495424009903/drma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:30:25.836485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}